ALNYLAM Trademark

Trademark Overview

On Friday, May 18, 2018, a trademark application was filed for ALNYLAM with the United States Patent and Trademark Office. The USPTO has given the ALNYLAM trademark a serial number of 87927601. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The ALNYLAM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1, Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), porphyria, hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1
alnylam

General Information

Serial Number87927601
Word MarkALNYLAM
Filing DateFriday, May 18, 2018
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6739619
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1, Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), porphyria, hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 26, 2018
Primary Code005
First Use Anywhere DateFriday, August 31, 2018
First Use In Commerce DateFriday, August 31, 2018

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, March 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, April 21, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 20, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 19, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, April 8, 2022USE AMENDMENT FILED
Friday, April 8, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, September 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 15, 2021SOU EXTENSION 5 GRANTED
Thursday, September 9, 2021SOU EXTENSION 5 FILED
Wednesday, September 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 9, 2021TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 9, 2021SOU EXTENSION 4 GRANTED
Friday, April 9, 2021SOU EXTENSION 4 FILED
Friday, April 9, 2021TEAS EXTENSION RECEIVED
Friday, October 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2020SOU EXTENSION 3 GRANTED
Wednesday, October 7, 2020SOU EXTENSION 3 FILED
Wednesday, October 7, 2020TEAS EXTENSION RECEIVED
Wednesday, April 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 30, 2020SOU EXTENSION 2 GRANTED
Monday, March 30, 2020SOU EXTENSION 2 FILED
Monday, March 30, 2020TEAS EXTENSION RECEIVED
Friday, October 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 9, 2019SOU EXTENSION 1 FILED
Wednesday, October 9, 2019TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 7, 2019ASSIGNED TO LIE
Wednesday, December 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 12, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 19, 2018NON-FINAL ACTION E-MAILED
Tuesday, June 19, 2018NON-FINAL ACTION WRITTEN
Monday, June 11, 2018ASSIGNED TO EXAMINER
Saturday, May 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 22, 2018NEW APPLICATION ENTERED

Related Keywords

alnylam amyloidosis attr porphyrias hereditary primary type hyperoxaluria hepatic mediated treatment